gonads Flashcards

menopause: define menopause and climacteric, explain the clinical features, summarise treatment options including the advantages and disadvantages

1
Q

define menopause

A

permanent cessation of menstuation due to loss of ovarian follicular activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

average age of menopause

A

51 (range from 45-55)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define climacteric

A

transition period to menopause, where periods become irregular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 major symptoms of menopause

A

hot flushes (head, neck, upper chest), urogenital atrophy and dyspareunia (difficult/painful sexual intercourse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

4 other symptoms of menopause

A

sleep disturbance (most common), depression, decreased libido, joint pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

normal hypothalamo-pituitary gonadal axis

A

hypothalamus -> GnRH -> anterior pituitary -> LH and FSH -> ovaries -> oestradiol and inhibin B -> negative feedback on hypothalamus and pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

hypothalamo-pituitary gonadal axis: hormonal changes during menopause

A

hypothalamus -> GnRH -> anterior pituitary -> increased LH and FSH -> ovaries -> reduced release of oestradiol and inhibin B -> reduced negative feedback on hypothalamus and pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

2 complications of menopause

A

osteoporosis, cardiovascular risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why does menopause cause osteoporosis, and effect on fracture risk

A

oestrogen deficiency causing loss of bone matrix; 10-fold increased fracture risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

menopause effect on cardiovascular disease risk

A

protected against CVD before menopause due to oestrogen, but have same risk as men by age of 70

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how can vasomotor symptoms (hot flushes) be controlled in menopause

A

hormone replacement therapy (always weigh risk and benefits)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

hormonal replacement therapy: what does oestrogen promote

A

endometrial proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hormonal replacement therapy: risk of using oestrogen, and why use combined oestrogen and progesterone

A

endometrial carcinoma, so combined to prevent endometrial hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what hormone replacement therapy would be prescribed following a hysterectomy

A

oestogen only as no endometrium as no uterus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2 hormone replacement therapy formulations and when given

A

cyclical: oestrogen everyday and progestogens every 12-14 days; continuous combined

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hormone replacement therapy formulations: 4 oestrogen preparations (amount, administration and how often)

A

oral estradiol (1mg), oral conjugated equine oestrogen (0.625 mg), transdermal (patch) oestradiol (50 microgram/day), intravaginal

17
Q

2 pharmacokinetic features of oestradiol

A

well absorbed but low bioavailability (majority undergoes first pass metabolism) so much higher dose vs transdermal skin patch or ethinyl oestradiol

18
Q

what is estrone sulphate

A

“conjugated” oestrogen

19
Q

what is ethinyl oestradiol and what does the ethinyl group do

A

semi-synthetic oestrogen; ethinyl group protects molecule from first pass metabolism

20
Q

besides enteral, how else can more oestrogens be administered

A

via transdermal skin patches, so require lower dose

21
Q

5 side effects of hormone replacement therapy

A

breast cancer, coronary heart disease, deep vein thrombosis, stroke, gallstones

22
Q

absolute risk of complications for healthy symptomatic postmenopausal women in 50s taking hormone replacement therapy for 5 years

A

very low

23
Q

hormone replacement therapy and coronary heart disease: what is important

A

timing of exposure (mean age in one study was 63 years, not a 50 year old)

24
Q

hormone replacement therapy and coronary heart disease: risk in younger menopausal women, or women < 10 years since menopause, or 50-59 years

A

no excess risk

25
Q

effect of oestrogen and synthetic progestins on lipid profile and endothelial function

A

oestrogen has beneficial effects on lipid profile and endothelial function (females have fewer CVD than men), but synthetic progestins negate these effects

26
Q

effects of oestrogen and synthetic progestins in older women (>60) with atherosclerosis, and effect on CVD risk

A

increased prothrombotic and proinflammatory effects, increasing CVD risk

27
Q

what is tibolone and what actions does it have

A

synthetic prohormone with oestrogenic, progestogenic and weak androgenic actions

28
Q

effect of tibolone on fracture risk

A

reduces fracture risk

29
Q

2 risks of using tibolone

A

increases stroke risk, possibly increases breast cancer risk

30
Q

what is raloxifene

A

selective oestrogen receptor modulator

31
Q

raloxifene oestrogenic effects in bone

A

reduces risk of vertebral fractures

32
Q

raloxifene anti-oestrogenic effects in breat and uterus

A

reduces breast cancer risk

33
Q

2 drawbacks of raloxifene

A

doesn’t reduce vasomotor symptoms of menopause (must treat with HRT), and increases risk of venous thromboembolism and fatal stroke

34
Q

tamoxifen effect on breast tissue and subsequent use

A

anti-oestrogenic effect, so used to treat oestrogen-dependent breast tumours and metastatic breast cancers

35
Q

define premature ovarian insufficiency, and % women affected

A

where menopause occurs before age of 40; occurs in 1% of women

36
Q

4 causes of premature ovarian insufficiency

A

autoimmune, surgery, chemotherapy, radiation